Vendor Neutral Archive (VNA) & PACS Market by Product Type (Department, Multi-department, Multi-site), Modality (CT, MRI, X-ray, Ultrasound, Mammo), Application (Cardio, Onco, Neuro), End User (Hospital, ASC, Diagnostic Center) - Global Forecast to 2031

icon1
USD 8.57 BN
MARKET SIZE, 2031
icon2
CAGR 8.9%
(2026-2031)
icon3
289
REPORT PAGES
icon4
316
MARKET TABLES

VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET SIZE, SHARE & GROWTH SNAPSHOT

vendor-neutral-archive-VNA-PACS-market Overview

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

The global vendor neutral archive (VNA) & PACS market is projected to grow from USD 5.60 billion in 2026 to USD 8.57 billion by 2031, at a CAGR of 8.9% during the forecast period. The market was valued at USD 5.10 billion in 2025. This growth is driven by the rapid digital transformation of healthcare infrastructure and increasing adoption of cloud-based archiving and AI-enhanced diagnostic tools that support remote workflows and data-driven care.

KEY TAKEAWAYS

  • By Region
    North America accounted for the largest share (42.9%) of the VNA & PACS market in 2025.
  • By Modality
    By modality, the X-ray segment accounted for the largest share (42.8%) of the VNA & PACS market in 2025.
  • By Deployment Model
    The cloud-based deployment models segment is projected to register the highest CAGR (10.4%) from 2026 to 2031.
  • By Product Type
    The VNA segment accounted for the largest market share in 2025.
  • By Vendor Type
    The independent vendors segment accounted for the largest share in 2025
  • By Application
    The cardiology segment accounted for the largest share in 2025.
  • By End User
    The hospital & clinics segment is projected to have the highest CAGR during the study period.

The growth in the medical imaging sector is predominantly fueled by the escalating volume of imaging data and a stronger regulatory push for EHR implementation. Additionally, the ongoing transition towards value-based care is prompting increased investments in scalable and interoperable imaging solutions. Key technological advancements, such as cloud-based storage, Al, and analytics integration, are significantly driving the adoption of VNA and PACS; these innovations facilitate improved clinical workflows, enhance data accessibility, and ultimately lead to better patient care outcomes.

TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS

The VNA & PACS market is being significantly disrupted by the convergence of cloud technologies, AI-enabled imaging workflows, and enterprise-wide data interoperability. Traditional siloed PACS are rapidly being replaced by cloud-native VNAs that support both DICOM and non-DICOM formats, enabling unified access across departments and care settings. The growing demand for remote diagnostics, teleradiology, and mobile access is accelerating the need for zero-footprint universal viewers, while rising cybersecurity threats are driving adoption of more secure, scalable, and compliant storage architectures.

vendor-neutral-archive-VNA-PACS-market Disruptions

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

MARKET DYNAMICS

Drivers
Impact
Level
  • Heightened investments in medical imaging technologies
  • Growing demand for streamlined healthcare data management solutions
RESTRAINTS
Impact
Level
  • High initial investment for implementing VNA and PACS solutions
  • Lack of standardized protocols and interoperability frameworks
OPPORTUNITIES
Impact
Level
  • Favorable government initiatives for better penetration of AI in medical imaging
  • Increasing medical imaging procedures and large imaging data silos
CHALLENGES
Impact
Level
  • Rising security concerns related to cloud-based image processing and analytics
  • Data security issues in healthcare settings

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Driver: Heightened investments in medical imaging technologies

Medical imaging employs various techniques, such as X-ray, Computed Tomography (CT), and Magnetic Resonance Imaging (MRI), to diagnose illnesses and provide insights into internal bodily conditions. Factors propelling investments in medical imaging technologies include governmental initiatives to modernize imaging facilities and research, the proliferation of diagnostic imaging centers, technological advancements in diagnostic imaging techniques, and patients’ growing preference for minimally invasive treatments

Restraint: High initial investment for implementing VNA and PACS solutions

The significant initial investment required for implementing VNA and PACS solutions poses a notable restraint on the market. Healthcare facilities considering the adoption of VNA and PACS technologies often face substantial upfront costs associated with infrastructure, software licenses, and training. These costs can present a considerable barrier to entry, particularly for smaller healthcare providers or facilities operating on a limited budget.

Opportunity: Favorable government initiatives for better penetration of AI in medical imaging

Innovative solutions, such as AI-based solutions, are used to interpret the massive volume of medical imaging and diagnosis data and transfer it into actionable, useful information that physicians, radiologists, and researchers can use to improve the quality of care. Realizing the benefits of AI-based solutions, government organizations in various countries are increasingly undertaking initiatives to increase the adoption of AI-based technologies in their respective healthcare systems

Challenge: Rising security concerns related to cloud-based image processing and analytics

In spite of the benefits offered by cloud computing, it is associated with several concerns related to integrity, availability, privacy, and confidentiality. Owing to the large number of issues related to cloud data storage, such as data breaches, data theft, and unavailability of cloud data, cloud service providers (CSPs) are required to ensure reliable data services to customers and their stored data. Although cloud computing has certain benefits, many users are still unwilling to store their confidential data in cloud data centers, such as personal health records, diagnostic imaging data, and government-sensitive files. Clients lose direct control over their data sources once the data is stored in a data center. CSPs are continuously striving to ensure data security by using mechanisms such as firewalls and virtualization. These mechanisms, however, cannot entirely provide complete data protection owing to network vulnerabilities and control issues CSPs face regarding cloud applications, hardware, and client data

VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES

COMPANY USE CASE DESCRIPTION BENEFITS
Offers enterprise imaging solutions with embedded VNA and PACS for multi-department use. Enhances interoperability and reduces data silos across radiology and cardiology systems.
Provides Synapse VNA for centralized archiving of imaging data from disparate systems. Improves data accessibility and long-term storage efficiency, supporting clinical decisions.
Delivers enterprise imaging PACS integrated with VNA for hospitals and imaging centers. Facilitates faster diagnosis and collaboration with unified access to image data.
Supplies scalable PACS and cloud-enabled VNAs for large healthcare networks. Lowers IT overhead while enabling secure, remote access to imaging records.
Offers cloud-based VNA solutions with AI-driven image management. Streamlines workflow and enhances diagnostic accuracy with intelligent data organization.

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET ECOSYSTEM

The VNA & PACS market ecosystem comprises a network of healthcare providers, imaging vendors, cloud service providers, and interoperability standards bodies working together to enable seamless storage, access, and exchange of medical images. Core participants include PACS/VNA software vendors, modality manufacturers (MRI, CT, etc.), cloud infrastructure providers, and cybersecurity firms. Supporting stakeholders like AI-powered imaging analytics companies, teleradiology platforms, and healthcare system integrators further enhances clinical workflows. This interconnected ecosystem is driven by a shared goal of achieving enterprise imaging, cross-vendor compatibility, and improved patient care across regions and healthcare settings.

vendor-neutral-archive-VNA-PACS-market Ecosystem

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET SEGMENTS

vendor-neutral-archive-VNA-PACS-market Segments

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

VNA & PACS Market, By Product Type

In 2025, the VNA segment held the largest share of the VNA & PACS market due to its capability to provide a centralized repository for storing medical images and related metadata in a standardized format, independent of specific imaging modalities or vendors. VNA enables efficient interoperability for data exchange across diverse systems and healthcare facilities, thereby enhancing collaboration and care coordination among providers. The VNA landscape can be delineated into three categories: departmental, multi-department, and multi-site VNA, each tailored to address the specific requirements of various levels within healthcare organizations. These solutions are essential for handling substantial volumes of imaging data, ensuring that medical images are readily accessible across multiple departments, locations, and systems; this access not only streamlines operational workflows but also optimizes patient care delivery. As the healthcare sector increasingly adopts value-based care models, the significance of comprehensive data management solutions, such as VNA, has escalated. Furthermore, VNA empowers healthcare organizations to leverage medical imaging data for initiatives related to population health management, predictive analytics, and personalized medicine. This strategic positioning has established VNA solutions as pivotal contributors to the evolving landscape of medical imaging and healthcare informatics.

VNA & PACS Market, By Deployment Model

The VNA & PACS market is segmented by deployment into cloud-based, on-premises, and hybrid deployment. The cloud-based segment is poised for robust growth throughout the forecast period, driven by a multitude of advantageous factors. Cloud-based VNA and PACS solutions eliminate the necessity for substantial investments in on- premises infrastructure, allowing healthcare organizations to leverage scalable storage and computing resources that can be dynamically configured according to fluctuating demand. This adaptability is particularly critical as healthcare entities grapple with the surging volumes of medical imaging data generated from diagnostic modalities such as X-rays, MRIs, and CT scans. Cloud service providers (CSPs) employ comprehensive security measures-including encryption, stringent access controls, and periodic security audits-to ensure the integrity and confidentiality of patient data. These protocols are essential for meeting regulatory compliance standards such as HIPAA and GDPR, mitigating the risks associated with potential data breaches, which are a major concern for healthcare organizations managing sensitive medical information. In addition, the cost-efficiency of cloud deployment models presents a compelling incentive for organizations aiming to curtail capital expenditures on physical infrastructure while capitalizing on the inherent flexibility of cloud storage solutions. The benefits of remote access and real-time monitoring afforded by cloud-based systems facilitate enhanced collaboration among healthcare professionals, enabling seamless access to imaging data across geographically dispersed locations while ensuring the health and security of the data remain intact.

VNA & PACS Market, By Modality

Based on modality, the VNA & PACS market is segmented into CT, mammography, MRI, ultrasound, X-rays, and PET. The CT segment held the largest market in 2025 due to the growing need for accurate and early diagnosis, advancements in technology, and the digitalization of healthcare. Additionally, CT scans play a crucial role in preventing unnecessary surgeries, improving cancer diagnosis and treatment, and enhancing patient care. Thus, the efficiency, versatility, and effectiveness of CT scans have made them indispensable in modern healthcare, driving their dominance in the VNA & PACS market as the preferred imaging modality for a diverse range of medical applications

VNA & PACS Market, By End User

Based on end-user, the VNA & PACS market is segmented into hospitals & clinics, diagnostic centers, ambulatory surgical centers, and other end users, including research and academic institutes. The hospitals & clinics segment dominates the end-user segment of the VNA & PACS market, as these healthcare facilities generate vast volumes of medical imaging data daily, necessitating robust solutions for managing, storing, and efficiently accessing this data. Moreover, these solutions provide a centralized repository for storing medical images and associated metadata in a standardized format, enabling seamless access and retrieval of patient information across different departments and facilities within hospitals and clinics. Owing to the increasing demand for personalized, data-driven care, the hospitals and clinics segment will remain at the forefront of innovation and investment in VNA and PACS solutions to meet the evolving needs of patients and healthcare professionals alike.

VNA & PACS Market, By Vendor type

Based on vendor type, the VNA & PACS market is segmented into independent vendors and third-party vendors. Third-party vendors are expected to be the fastest-growing during the forecast period due to their ability to provide flexible, interoperable solutions that integrate across multi-vendor imaging environments. Their offerings often include cost-effective cloud-based storage, enhanced data migration services, and scalable solutions that reduce IT complexity. Additionally, the increasing demand for cross-enterprise data sharing and the shift toward subscription-based models further fuel the growth of third-party VNA & PACS vendors.

VNA & PACS Market, By Application

Based on application, the VNA & PACS market is segmented into cardiology, orthopedic, oncology, neurology, obstetrics & gynecology, and other applications. The cardiology segment held the largest market share in 2025 due to the high volume of imaging procedures, such as echocardiograms, CT, and MRI scans, which require efficient storage and retrieval systems. The rising prevalence of cardiovascular diseases, growing adoption of advanced imaging technologies for early diagnosis, and increasing integration of AI-driven analytics in cardiac imaging are key drivers supporting the segment's dominance. Moreover, the demand for seamless cross-departmental access to imaging data to support timely interventions in critical care further propels market growth.

REGION

APAC is estimated to register the highest CAGR during the forecast period

The VNA & PACS market in APAC is projected to register the highest CAGR during the forecast period. The growth of this region is due to rising medical imaging investments and technological advancements in diagnostic imaging modalities. Moreover, advancements in technology and the growing prevalence of cloud computing are making VNA and PACS more accessible and affordable in APAC. As healthcare providers in this region continue to prioritize efficiency, accessibility, and quality of care, VNA and PACS solutions will play a pivotal role in driving healthcare transformation and improving patient outcomes across the region.

vendor-neutral-archive-VNA-PACS-market Region

VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: COMPANY EVALUATION MATRIX

In the VNA & PACS market matrix, Agfa Healthcare (Star) leads with a strong market presence and comprehensive imaging portfolio, offering interoperable VNA and PACS solutions that support multi-department enterprise imaging across global healthcare networks. Intelerad (Emerging Leader) is rapidly gaining traction with its cloud-native PACS and enterprise imaging platforms, delivering scalable and flexible solutions that appeal to mid-sized and large imaging providers. While Agfa dominates through a broad installed base and end-to-end imaging workflows, Intelerad shows strong momentum to advance toward the leaders' quadrant as cloud adoption and demand for integrated, AI-ready platforms continue to rise.

vendor-neutral-archive-VNA-PACS-market Evaluation Metrics

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

KEY MARKET PLAYERS

MARKET SCOPE

REPORT METRIC DETAILS
Market Size in 2025 (Value) (Base Year) USD 5.10 BN
Market Size in 2026 (Value) (Estimated Year) USD 5.60 Billion
Market Forecast in 2031 (Value) (Forecast Year) USD 8.57 Billion
CAGR 8.9%
Years Considered 2024–2031
Base Year 2025
Forecast Period 2026–2031
Units Considered USD Billion
Report Coverage Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments Covered
  • By Product type: VNA and PACS
  • Modality:
    • CT
    • Mammography
    • MRI
    • Ultrasound
    • X-Rays
    • and PET
  • Deployment Model:
    • On-Premise
    • Cloud-Based
    • and Hybrid Model
  • Vendor type: Independent vendor and Third-party vendor
  • Application:
    • Cardiology
    • Orthopedic
    • Oncology
    • Neurology
    • Obstetrics & Gynecology
    • and others
  • End user:
    • Hospitals & Clinics
    • Diagnostic Centers
    • and others.
Regions Covered North America, Asia Pacific, Europe, the Middle East & Africa, Latin America

WHAT IS IN IT FOR YOU: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET REPORT CONTENT GUIDE

vendor-neutral-archive-VNA-PACS-market Content Guide

DELIVERED CUSTOMIZATIONS

We have successfully delivered the following deep-dive customizations:

CLIENT REQUEST CUSTOMIZATION DELIVERED VALUE ADDS
Pricing and distribution channel of VNA & PACS market Delivered detailed analysis of pricing models (subscription, perpetual license, tiered storage) and distribution channels (direct sales, system integrators, cloud marketplaces, and OEM partnerships) Enabled the client to refine their go-to-market strategy and align pricing to competitive and buyer expectations

RECENT DEVELOPMENTS

  • April 2025 : Siemens Healthineers (Germany) and Tower Health (US) unveiled a 10-year value partnership to upgrade imaging systems and digital tools and enhance diagnostic capabilities.
  • March 2025 : GE Healthcare (US) launched the Genesis Cloud Suite, an enterprise imaging SaaS portfolio offering edge, storage, VNA, and data migration solutions to improve workflow efficiency, precision, and IT resource optimization for healthcare providers.
  • March 2025 : FUJIFILM Healthcare Americas (US) partnered with AWS (US) to enhance digital pathology and cloud integration to streamline data lifecycle management and optimize storage of large pathology files within Fujifilm's Synapse Pathology platform.

 

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
1
INTRODUCTION
 
 
 
15
2
EXECUTIVE SUMMARY
 
 
 
 
3
PREMIUM INSIGHTS
 
 
 
 
4
MARKET OVERVIEW
Explains the evolving landscape through demand-side drivers, supply-side constraints, and opportunity hotspots.
 
 
 
 
 
4.1
INTRODUCTION
 
 
 
 
4.2
MARKET DYNAMICS
 
 
 
 
 
4.2.1
DRIVERS
 
 
 
 
4.2.2
RESTRAINTS
 
 
 
 
4.2.3
OPPORTUNITIES
 
 
 
 
4.2.4
CHALLENGES
 
 
 
4.3
UNMET NEEDS AND WHITE SPACES
 
 
 
 
4.4
INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
 
 
 
 
4.5
STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
 
 
 
5
INDUSTRY TRENDS
Provides a snapshot of current market scenario, value chain context, and factors impacting competitive intensity.
 
 
 
 
 
5.1
PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
5.2
MACROECONOMICS INDICATORS
 
 
 
 
 
5.2.1
INTRODUCTION
 
 
 
 
5.2.2
GDP TRENDS AND FORECAST
 
 
 
 
5.2.3
TRENDS IN GLOBAL HEALTHCARE IT INDUSTRY
 
 
 
5.3
VALUE CHAIN ANALYSIS
 
 
 
 
 
5.4
ECOSYSTEM ANALYSIS
 
 
 
 
 
5.5
PRICING ANALYSIS
 
 
 
 
 
 
5.5.1
INDICATIVE PRICING FOR VNA & PACS MARKET, BY PRODUCT TYPE (2025)
 
 
 
 
5.5.2
INDICATIVE PRICING FOR VNA & PACS MARKET, BY REGION (2025)
 
 
 
5.6
KEY CONFERENCES AND EVENTS, 2026–2028
 
 
 
 
5.7
TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
 
 
 
 
5.8
INVESTMENT AND FUNDING SCENARIO
 
 
 
 
5.9
CASE STUDY ANALYSIS
 
 
 
 
5.10
IMPACT OF 2026 US TARIFF – VNA & PACS MARKET
 
 
 
 
 
 
5.10.1
INTRODUCTION
 
 
 
 
5.10.2
KEY TARIFF RATES
 
 
 
 
5.10.3
PRICE IMPACT ANALYSIS
 
 
 
 
5.10.4
IMPACT ON COUNTRIES/REGIONS
 
 
 
 
 
5.10.4.1
US
 
 
 
 
5.10.4.2
EUROPE
 
 
 
 
5.10.4.3
APAC
 
 
 
5.10.5
IMPACT ON END-USE INDUSTRIES
 
 
6
TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
 
 
 
 
 
6.1
KEY EMERGING TECHNOLOGIES
 
 
 
 
 
6.1.1
DIGITAL IMAGING AND COMMUNICATIONS IN MEDICINE (DICOM)
 
 
 
 
6.1.2
ENTERPRISE IMAGING SOLUTIONS
 
 
 
 
6.1.3
CLOUD-BASED STORAGE AND SERVICES
 
 
 
6.2
COMPLEMENTARY TECHNOLOGIES
 
 
 
 
 
6.2.1
IMAGE EXCHANGE NETWORKS.
 
 
 
 
6.2.2
DATA ANALYTICS AND BUSINESS INTELLIGENCE
 
 
 
6.3
ADJACENT TECHNOLOGIES
 
 
 
 
 
6.3.1
HEALTH INFORMATION EXCHANGE (HIE)
 
 
 
6.4
TECHNOLOGY/PRODUCT ROADMAP
 
 
 
 
6.5
PATENT ANALYSIS
 
 
 
 
 
6.6
FUTURE APPLICATIONS
 
 
 
7
REGULATORY LANDSCAPE
 
 
 
 
 
7.1
REGIONAL REGULATIONS AND COMPLIANCE
 
 
 
 
 
7.1.1
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
7.1.2
INDUSTRY STANDARDS
 
 
8
CUSTOMER LANDSCAPE & BUYER BEHAVIOR
 
 
 
 
 
8.1
DECISION-MAKING PROCESS
 
 
 
 
8.2
BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA
 
 
 
 
8.3
ADOPTION BARRIERS & INTERNAL CHALLENGES
 
 
 
 
8.4
UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
 
 
 
 
8.5
MARKET PROFITABILITY
 
 
 
9
VNA & PACS MARKET, BY PRODUCT TYPE (MARKET SIZE & FORECAST TO 2031)
Market Size, Volume & Forecast – USD Million
 
 
 
 
 
9.1
INTRODUCTION
 
 
 
 
9.2
VNA
 
 
 
 
 
9.2.1
DEPARTMENT VNA
 
 
 
 
9.2.2
MULTI-DEPARTMENT VNA
 
 
 
 
9.2.3
MULTI-SITE VNA
 
 
 
9.3
PACS
 
 
 
 
 
9.3.1
DEPARTMENT PACS
 
 
 
 
9.3.2
MULTI-DEPARTMENT PACS
 
 
 
 
9.3.3
MULTI-SITE PACS
 
 
10
VNA & PACS MARKET, BY MODALITY (MARKET SIZE & FORECAST TO 2031)
Market Size, Volume & Forecast – USD Million
 
 
 
 
 
10.1
INTRODUCTION
 
 
 
 
10.2
CT
 
 
 
 
10.3
MAMMOGRAPHY
 
 
 
 
10.4
MRI
 
 
 
 
10.5
ULTRASOUND
 
 
 
 
10.6
X-RAYS
 
 
 
 
10.7
PET
 
 
 
11
VNA & PACS MARKET, BY DEPLOYMENT (MARKET SIZE & FORECAST TO 2031)
Market Size, Volume & Forecast – USD Million
 
 
 
 
 
11.1
INTRODUCTION
 
 
 
 
11.2
ON-PREMISE DEPLOYMENT
 
 
 
 
11.3
CLOUD-BASED DEPLOYMENT
 
 
 
 
11.4
HYBRID DEPLOYMENT
 
 
 
12
VNA & PACS MARKET, BY VENDOR TYPE (MARKET SIZE & FORECAST TO 2031)
Market Size, Volume & Forecast – USD Million
 
 
 
 
 
12.1
INTRODUCTION
 
 
 
 
12.2
INDEPENDENT VENDOR
 
 
 
 
12.3
THIRD-PARTY VENDOR
 
 
 
13
VNA & PACS MARKET, BY APPLICATION (MARKET SIZE & FORECAST TO 2031)
Market Size, Volume & Forecast – USD Million
 
 
 
 
 
13.1
INTRODUCTION
 
 
 
 
13.2
CARDIOLOGY
 
 
 
 
13.3
ORTHOPEDIC
 
 
 
 
13.4
ONCOLOGY
 
 
 
 
13.5
NEUROLOGY
 
 
 
 
13.6
OBSTETRICS AND GYNECOLOGY
 
 
 
 
13.7
OTHER APPLICATIONS
 
 
 
14
VNA & PACS MARKET, BY END USER (MARKET SIZE & FORECAST TO 2031)
Market Size, Volume & Forecast – USD Million
 
 
 
 
 
14.1
INTRODUCTION
 
 
 
 
14.2
HOSPITALS & CLINICS
 
 
 
 
14.3
DIAGNOSTICS CENTERS
 
 
 
 
14.4
AMBULATORY SURGICAL CENTERS
 
 
 
 
14.5
OTHER END USERS
 
 
 
15
VNA & PACS MARKET, BY REGION (MARKET SIZE & FORECAST TO 2031)
Market Size, Volume & Forecast – USD Million
 
 
 
 
 
15.1
INTRODUCTION
 
 
 
 
15.2
NORTH AMERICA
 
 
 
 
 
15.2.1
US
 
 
 
 
15.2.2
CANADA
 
 
 
15.3
EUROPE
 
 
 
 
 
15.3.1
GERMANY
 
 
 
 
15.3.2
FRANCE
 
 
 
 
15.3.3
UK
 
 
 
 
15.3.4
ITALY
 
 
 
 
15.3.5
SPAIN
 
 
 
 
15.3.6
REST OF EUROPE
 
 
 
15.4
ASIA PACIFIC
 
 
 
 
 
15.4.1
CHINA
 
 
 
 
15.4.2
JAPAN
 
 
 
 
15.4.3
INDIA
 
 
 
 
15.4.4
AUSTRALIA
 
 
 
 
15.4.5
SOUTH KOREA
 
 
 
 
15.4.6
REST OF ASIA PACIFIC
 
 
 
15.5
LATIN AMERICA
 
 
 
 
 
15.5.1
BRAZIL
 
 
 
 
15.5.2
MEXICO
 
 
 
 
15.5.3
REST OF LATIN AMERICA
 
 
 
15.6
MIDDLE EAST & AFRICA
 
 
 
 
 
15.6.1
GCC COUNTRIES
 
 
 
 
 
15.6.1.1
SAUDI ARABIA
 
 
 
 
15.6.1.2
UAE
 
 
 
 
15.6.1.3
REST OF GCC
 
 
 
15.6.2
SOUTH AFRICA
 
 
 
 
15.6.3
REST OF MIDDLE EAST & AFRICA
 
 
16
COMPETITIVE LANDSCAPE
 
 
 
 
 
STRATEGIC ASSESSMENT OF LEADING PLAYERS, MARKET SHARE, REVENUE ANALYSIS, COMPANY POSITIONING, AND COMPETITIVE BENCHMARKS INFLUENCING MARKET POTENTIAL
 
 
 
 
 
 
16.1
OVERVIEW
 
 
 
 
16.2
KEY PLAYER COMPETITIVE STRATEGIES/RIGHT TO WIN
 
 
 
 
16.3
REVENUE ANALYSIS (2021-2025)
 
 
 
 
 
16.4
MARKET SHARE ANALYSIS (2025)
 
 
 
 
 
16.5
BRAND/SOFTWARE COMPARATIVE ANALYSIS
 
 
 
 
16.6
COMPANY EVALUATION MATRIX: KEY PLAYERS,
 
 
 
 
 
 
16.6.1
STARS
 
 
 
 
16.6.2
EMERGING LEADERS
 
 
 
 
16.6.3
PERVASIVE PLAYERS
 
 
 
 
16.6.4
PARTICIPANTS
 
 
 
 
16.6.5
COMPANY FOOTPRINT: KEY PLAYERS,
 
 
 
 
 
16.6.5.1
COMPANY FOOTPRINT
 
 
 
 
16.6.5.2
REGION FOOTPRINT
 
 
 
 
16.6.5.3
PRODUCT TYPE FOOTPRINT
 
 
 
 
16.6.5.4
DEPLOYMENT FOOTPRINT
 
 
 
 
16.6.5.5
END USER FOOTPRINT
 
 
16.7
COMPANY EVAULATION MATRIX: STARTUPS/SMES,
 
 
 
 
 
 
16.7.1
PROGRESSIVE COMPANIES
 
 
 
 
16.7.2
DYNAMIC COMPANIES
 
 
 
 
16.7.3
RESPONSIVE COMPANIES
 
 
 
 
16.7.4
STARTING BLOCKS
 
 
 
 
16.7.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES,
 
 
 
 
 
16.7.5.1
DETAILED LIST OF KEY STARTUPS/SMES
 
 
 
 
16.7.5.2
COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
 
 
16.8
COMPANY VALUATION AND FINANCIAL METRICS
 
 
 
 
16.9
COMPETITIVE SCENARIOS
 
 
 
 
 
16.9.1
PRODUCT LAUNCHES & UPGRADES
 
 
 
 
16.9.2
DEALS
 
 
 
 
16.9.3
EXPANSIONS
 
 
 
 
16.9.4
OTHERS
 
 
17
COMPANY PROFILES
 
 
 
 
 
IN-DEPTH REVIEW OF COMPANIES, PRODUCTS, SERVICES, RECENT INITIATIVES, AND POSITIONING STRATEGIES IN THE VNA & PACS MARKET LANDSCAPE
 
 
 
 
 
17.1
KEY PLAYERS
 
 
 
 
 
17.1.1
KONINKLIJKE PHILIPS N.V.
 
 
 
 
17.1.2
SIEMENS HEALTHINEERS AG
 
 
 
 
17.1.3
GE HEALTHCARE
 
 
 
 
17.1.4
FUJIFILM HOLDINGS CORPORATION
 
 
 
 
17.1.5
CANON MEDICAL SYSTEMS CORPORATION
 
 
 
 
17.1.6
AGFA-GEVAERT GROUP
 
 
 
 
17.1.7
MERATIVE
 
 
 
 
17.1.8
HYLAND SOFTWARE, INC.
 
 
 
 
17.1.9
SECTRA AB
 
 
 
 
17.1.10
ESAOTE SPA
 
 
 
 
17.1.11
VISUS HEALTH IT GMBH
 
 
 
 
17.1.12
PAXERAHEALTH
 
 
 
 
17.1.13
NOVARAD CORPORATION
 
 
 
 
17.1.14
BRIDGEHEAD SOFTWARE LTD.
 
 
 
 
17.1.15
CANOPY PARTNERS
 
 
 
 
17.1.16
ASPYRA, LLC
 
 
 
 
17.1.17
POSTDICOM
 
 
 
 
17.1.18
CRELIOHEALTH
 
 
 
 
17.1.19
MEDICASOFT
 
 
 
17.2
OTHER PLAYERS
 
 
 
 
 
17.2.1
ADVAHEALTH SOLUTIONS.
 
 
 
 
17.2.2
SOFTTEAM SOLUTIONS PVT LTD.
 
 
 
 
17.2.3
ARO SYSTEMS
 
 
 
 
17.2.4
CENTRAL DATA NETWORKS
 
 
 
 
17.2.5
ONEPACS
 
 
 
 
17.2.6
DEDALUS S.P.A
 
 
18
RESEARCH METHODOLOGY
 
 
 
 
 
18.1
RESEARCH DATA
 
 
 
 
 
18.1.1
SECONDARY DATA
 
 
 
 
 
18.1.1.1
KEY DATA FROM SECONDARY SOURCES
 
 
 
18.1.2
PRIMARY DATA
 
 
 
 
 
18.1.2.1
KEY DATA FROM PRIMARY SOURCES
 
 
 
 
18.1.2.2
KEY PRIMARY PARTICIPANTS
 
 
 
 
18.1.2.3
BREAKDOWN OF PRIMARY INTERVIEWS
 
 
 
 
18.1.2.4
KEY INDUSTRY INSIGHTS
 
 
18.2
MARKET SIZE ESTIMATION
 
 
 
 
 
18.2.1
BOTTOM-UP APPROACH
 
 
 
 
18.2.2
TOP-DOWN APPROACH
 
 
 
 
18.2.3
BASE NUMBER CALCULATION
 
 
 
18.3
MARKET FORECAST APPROACH
 
 
 
 
 
18.3.1
SUPPLY SIDE
 
 
 
 
18.3.2
DEMAND SIDE
 
 
 
18.4
DATA TRIANGULATION
 
 
 
 
18.5
FACTOR ANALYSIS
 
 
 
 
18.6
RESEARCH ASSUMPTIONS
 
 
 
 
18.7
RESEARCH LIMITATIONS AND RISK ASSESSMENT
 
 
 
19
APPENDIX
 
 
 
 
 
19.1
DISCUSSION GUIDE
 
 
 
 
19.2
KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
 
 
 
 
19.3
CUSTOMIZATION OPTIONS
 
 
 
 
19.4
RELATED REPORTS
 
 
 
 
19.5
AUTHOR DETAILS
 
 
 

Methodology

The study involved five major activities to estimate the current size of the VNA & PACS market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.

Secondary Research

In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for the study of the VNA PACS market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.

Primary Research

Extensive primary research was conducted after acquiring basic knowledge about the VNA & PACS market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand side (Hospital directors, Hospital Vice Presidents, Department heads, and Critical care specialists ) and supply side (such as C-level and D-level executives, technology experts, product managers, marketing and sales managers, among others) across five major regions North America, Europe, the Asia Pacific, Latin America, Middle East, and Africa. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.

BREAKDOWN OF PRIMARIES

Vendor Neutral Archive (VNA) & PACS Market
 Size, and Share

Note 2: Tiers of companies are defined based on their total revenues in 2025. Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = <USD 500 million.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the VNA & PACS market. These methods were also used extensively to estimate the size of various subsegments in the market.

Vendor Neutral Archive (VNA) & PACS Market Top Down and Bottom Up Approach

Data Triangulation

After arriving at the overall market size using the market size estimation processes, the market was split into several segments and subsegments. To complete the overall market engineering process and determine the exact statistics for each market segment and sub-segment, data triangulation and market breakdown procedures were employed where applicable. The data was triangulated by examining various factors and trends on both the demand and supply sides of the VNA & PACS market.

Market Definition

VNA and PACS are medical imaging technologies that offer cost-effective storage and easy access to images from various modalities. These solutions are essential elements of modern healthcare IT infrastructure, enabling the efficient and secure digitization, storage, retrieval, and sharing of medical imaging data.

Key Stakeholders

  • VNA & PACS vendors
  • Government bodies
  • Healthcare service providers
  • Clinical/Physician centers
  • Healthcare professionals
  • Health IT service providers
  • Healthcare associations/institutes
  • Ambulatory care centers
  • Venture capitalists
  • Distributors and resellers
  • Maintenance and support service providers
  • Integration service providers
  • Healthcare players

Report Objectives

  • To define, describe, and forecast the VNA & PACS market based on product type, modality, deployment, vendor type, application, end user, and region
  • To provide detailed information regarding the factors influencing the growth of the market (drivers, restraints, opportunities, and challenges)
  • To strategically analyze micromarkets¹ with respect to individual growth trends, prospects, and contributions to the market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of market segments in North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
  • To profile key players and comprehensively analyze their product portfolios, market positions, and core competencies²
  • To track and analyze competitive developments such as product launches and approvals; joint ventures, partnerships, & collaborations; acquisitions; and contracts in the VNA & PACS market.

Available customizations:

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

  • Product Analysis: Product matrix, which gives a detailed comparison of the product portfolios of each company.
  • Geographic Analysis: Further breakdown of Latin America, Europe, and the Middle East & Africa VNA & PACS into specific countries

 

Growth Signals

See competitors, opportunities & growth signals

Explore Intelligence

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Vendor Neutral Archive (VNA) & PACS Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

TESTIMONIALS

Growth opportunities and latent adjacency in Vendor Neutral Archive (VNA) & PACS Market

Marcus

Apr, 2026

As a healthcare IT professional, how can VNA and PACS integration be optimized for better interoperability and imaging workflow efficiency?.

Carlos

Apr, 2026

How is VNA configuration and system integration improving data accessibility and imaging management across healthcare networks?.

Griffin

Apr, 2026

How can hospitals effectively integrate radiology and cardiology PACS systems for improved imaging workflow and interoperability?.

Blake

Apr, 2026

How are third-party VNA providers and AI integration improving medical imaging data management and accessibility?.

Jordan

Apr, 2026

How are cloud-based VNA systems improving workflow integration, data storage, and interoperability in healthcare imaging?.

Ethan

Apr, 2026

How are healthcare organizations differentiating between VNA and PACS, and what are the key benefits of each system in imaging workflows?.

Mason

Apr, 2026

From a hospital IT standpoint, what are the biggest barriers to adopting Vendor Neutral Archive (VNA) solutions alongside legacy PACS systems?.

Logan

Apr, 2026

How do you evaluate the ROI of implementing a VNA, especially for mid-sized healthcare providers with limited budgets?.

Carter

Apr, 2026

Do you see scalability challenges as imaging volumes grow with AI-driven diagnostics and multi-modality imaging?.

Avery

Apr, 2026

How confident can healthcare organizations be about data security and compliance when shifting to VNA, particularly in cloud deployments?.

Harper

Apr, 2026

What future opportunities do you see emerging in the VNA/PACS market as healthcare becomes more data-driven?.

Show More
DMCA.com Protection Status